• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病伴或不伴并存慢性阻塞性肺疾病的全身炎症:选定标志物分析。

Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.

机构信息

Department of Internal Medicine, Pulmonology and Allergology, Medical University of Warsaw, Poland.

出版信息

Arch Med Sci. 2012 Jul 4;8(3):477-83. doi: 10.5114/aoms.2012.29403.

DOI:10.5114/aoms.2012.29403
PMID:22852003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3400913/
Abstract

INTRODUCTION

Low-grade systemic inflammation plays an important role in the pathogenesis and natural history of chronic obstructive pulmonary disease (COPD) and peripheral arterial disease (PAD). The aim of the study was to analyze plasma concentrations of selected markers of inflammation in patients suffering from PAD with or without coexistent COPD.

MATERIAL AND METHODS

Thirty patients (6 women) with advanced PAD (at least IIb stage according to Fontaine scale) hospitalized due to critical limb ischemia were examined. In all patients spirometry was performed to confirm or exclude COPD. Plasma concentration of IL-6, IL-8 and TNF-α was measured using ELISA method. Statistical analysis was performed according to COPD status and according to smoking status independently.

RESULTS

In the whole group of patients with PAD, COPD was recognized in 14 cases (for the first time in 10 cases). All patients were smokers (46.7% current, 53.3% ex-smokers). We found a significant correlation between FEV1%N (percent of norm of first second expiratory volume) and the number of years of smoking (r = -0.39; p < 0.05). We found similar concentrations of IL-6 (2.54 pg/ml vs. 2.31 pg/ml), IL-8 (8.55 pg/ml vs. 8.14 pg/ml, TNF-α (0.72 pg/ml vs. 1.75 pg/ml) in the COPD(+) group in comparison to the COPD(-) group (differences were not significant). We observed significant positive correlations (p < 0.05) between concentrations of measured markers and significant negative correlations between pain free walking distance and these markers.

CONCLUSIONS

Our study confirmed coexistence of PAD with COPD. The character of inflammation is similar in these smoking-related diseases.

摘要

简介

低度全身炎症在慢性阻塞性肺疾病(COPD)和外周动脉疾病(PAD)的发病机制和自然史中起着重要作用。本研究的目的是分析患有 PAD 合并或不合并 COPD 的患者的炎症标志物血浆浓度。

材料与方法

检查了 30 名(6 名女性)因严重肢体缺血而住院的晚期 PAD 患者(根据 Fontaine 量表至少为 IIb 期)。所有患者均进行了肺量测定以确认或排除 COPD。使用 ELISA 法测量 IL-6、IL-8 和 TNF-α 的血浆浓度。根据 COPD 状态和吸烟状态分别进行统计分析。

结果

在所有 PAD 患者中,有 14 例(首次在 10 例中)被诊断为 COPD。所有患者均为吸烟者(46.7% 当前吸烟者,53.3% 戒烟者)。我们发现 FEV1%N(第一秒呼气量占正常百分比)与吸烟年限之间存在显著相关性(r = -0.39;p <0.05)。我们发现 COPD(+) 组与 COPD(-) 组的 IL-6(2.54 pg/ml 对 2.31 pg/ml)、IL-8(8.55 pg/ml 对 8.14 pg/ml)和 TNF-α(0.72 pg/ml 对 1.75 pg/ml)浓度相似(差异无统计学意义)。我们观察到测量标志物浓度之间存在显著正相关(p <0.05),并且无疼痛行走距离与这些标志物之间存在显著负相关。

结论

我们的研究证实了 PAD 与 COPD 的共存。这些与吸烟有关的疾病的炎症特征相似。

相似文献

1
Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.外周动脉疾病伴或不伴并存慢性阻塞性肺疾病的全身炎症:选定标志物分析。
Arch Med Sci. 2012 Jul 4;8(3):477-83. doi: 10.5114/aoms.2012.29403.
2
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.
3
Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.主动吸烟对慢性阻塞性肺疾病患者气道和全身炎症谱的影响。
Am J Med Sci. 2013 Jun;345(6):440-5. doi: 10.1097/MAJ.0b013e31825f32a7.
4
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.慢性阻塞性肺疾病严重程度与潜在生物标志物的相关性。
Immunol Lett. 2018 Apr;196:1-10. doi: 10.1016/j.imlet.2018.01.004. Epub 2018 Jan 9.
5
Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?血管内皮生长因子:一种反映健康吸烟者及慢性阻塞性肺疾病支气管炎型患者气道炎症的血管生成因子?
Respir Res. 2007 Jul 15;8(1):53. doi: 10.1186/1465-9921-8-53.
6
Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients.COPD 患者的吸烟状况与肿瘤坏死因子-α介导的全身炎症。
J Inflamm (Lond). 2010 Jun 9;7:29. doi: 10.1186/1476-9255-7-29.
7
[The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病吸烟者肺动脉中白细胞介素-16和CXC趋化因子受体3表达的变化及意义]
Zhonghua Nei Ke Za Zhi. 2009 Oct;48(10):841-5.
8
Systemic inflammation in COPD in relation to smoking status.慢性阻塞性肺疾病(COPD)中的全身炎症与吸烟状况的关系。
Multidiscip Respir Med. 2011 Aug 31;6(4):214-9. doi: 10.1186/2049-6958-6-4-214.
9
Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的皮肤状况及其与全身炎症的关系。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 11;12:2407-2415. doi: 10.2147/COPD.S141805. eCollection 2017.
10
Systemic inflammation in patients with COPD and pulmonary hypertension.慢性阻塞性肺疾病(COPD)合并肺动脉高压患者的全身炎症
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.

引用本文的文献

1
Tissue metabolomic profiling to reveal the therapeutic mechanism of reduning injection on LPS-induced acute lung injury rats.组织代谢组学分析揭示热毒宁注射液对脂多糖诱导的急性肺损伤大鼠的治疗机制。
RSC Adv. 2018 Mar 13;8(18):10023-10031. doi: 10.1039/c7ra13123b. eCollection 2018 Mar 5.
2
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis.血管加压素依赖性脓毒症后四肢威胁和截肢的流行病学。
Ann Am Thorac Soc. 2022 Apr;19(4):625-632. doi: 10.1513/AnnalsATS.202105-547OC.
3
Oxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary disease.

本文引用的文献

1
[Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].[波兰肺病学会关于慢性阻塞性肺疾病(COPD)诊断与治疗的建议]
Pneumonol Alergol Pol. 2010;78(5):318-47.
2
Serum interleukin-6 levels in colorectal cancer patients--a summary of published results.结直肠癌患者血清白细胞介素-6 水平--已发表结果总结。
Int J Colorectal Dis. 2010 Feb;25(2):135-40. doi: 10.1007/s00384-009-0818-8. Epub 2009 Nov 7.
3
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
内皮依赖性血管舒张的氧依赖性:在慢性阻塞性肺疾病中的重要性。
Arch Med Sci. 2018 Mar;14(2):297-306. doi: 10.5114/aoms.2016.58854. Epub 2016 Mar 24.
4
Total phenolic, flavonoid, alkaloid and iridoid content and preventive effect of Lider-7-tang on lipopolysaccharide-induced acute lung injury in rats.利得-7汤对大鼠脂多糖诱导的急性肺损伤的总酚、黄酮、生物碱和环烯醚萜含量及预防作用
Braz J Med Biol Res. 2017 Oct 19;50(12):e5916. doi: 10.1590/1414-431X20175916.
5
Lower extremity and carotid artery disease in COPD.慢性阻塞性肺疾病中的下肢和颈动脉疾病
ERJ Open Res. 2016 Oct 26;2(4). doi: 10.1183/23120541.00037-2016. eCollection 2016 Oct.
6
Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease.血管紧张素转换酶基因插入/缺失多态性对慢性阻塞性肺疾病发生风险及病程的影响
Arch Med Sci. 2016 Apr 1;12(2):279-87. doi: 10.5114/aoms.2015.50757. Epub 2016 Apr 12.
7
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.外周动脉疾病的计算药物重新定位:抗炎和促血管生成疗法的预测
Front Pharmacol. 2015 Aug 25;6:179. doi: 10.3389/fphar.2015.00179. eCollection 2015.
8
Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress.槲皮素通过抑制炎症和氧化应激反应,对脂多糖诱导的大鼠急性肺损伤具有保护作用。
Arch Med Sci. 2015 Apr 25;11(2):427-32. doi: 10.5114/aoms.2015.50975. Epub 2015 Apr 23.
9
Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia.自体骨髓单个核细胞联合基因治疗作为重症肢体缺血患者的最后治疗手段。
Arch Med Sci. 2015 Apr 25;11(2):325-31. doi: 10.5114/aoms.2013.39935. Epub 2014 Jul 23.
10
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease.慢性心力衰竭和慢性阻塞性肺疾病住院患者的潜在药物-药物相互作用。
Arch Med Sci. 2014 Oct 27;10(5):920-32. doi: 10.5114/aoms.2014.46212. Epub 2014 Oct 23.
[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.
4
Exercise as a mean to control low-grade systemic inflammation.运动作为控制低度全身性炎症的一种手段。
Mediators Inflamm. 2008;2008:109502. doi: 10.1155/2008/109502. Epub 2009 Jan 11.
5
Chronic obstructive pulmonary disease in patients admitted with heart failure.因心力衰竭入院患者的慢性阻塞性肺疾病
J Intern Med. 2008 Oct;264(4):361-9. doi: 10.1111/j.1365-2796.2008.01975.x. Epub 2008 Jun 5.
6
Systemic inflammation, genetic susceptibility and lung function.全身炎症、遗传易感性与肺功能。
Eur Respir J. 2008 Jul;32(1):92-7. doi: 10.1183/09031936.00052507. Epub 2008 Apr 2.
7
Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.慢性阻塞性肺疾病和哮喘中的全身炎症:异同点
Respirology. 2008 Jan;13(1):128-33. doi: 10.1111/j.1440-1843.2007.01170.x.
8
Complex chronic comorbidities of COPD.慢性阻塞性肺疾病的复杂慢性合并症
Eur Respir J. 2008 Jan;31(1):204-12. doi: 10.1183/09031936.00114307.
9
Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.慢性阻塞性肺疾病中的全身炎症:急性加重的作用。
Proc Am Thorac Soc. 2007 Dec;4(8):626-34. doi: 10.1513/pats.200706-071TH.
10
Risk factor awareness in patients with peripheral arterial disease.
J Cardiovasc Surg (Torino). 2007 Dec;48(6):735-40.